Latest news
LifeMine Therapeutics Raises $263M in Watertown, MA - HoodlineHoodline · Thu, 06 Aug 2026 18:42:10 GMTWith $263M, LifeMine unearths a new drug for organ transplants - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 13:40:35 GMTLifeMine CEO Verdine Raises $263M From Bezos and Gates to Replace Tacrolimus, the Transplant Drug That Destroys Kidneys - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 13:09:00 GMTLifeMine raises $263M in mission to improve organ transplant aftercare - BioSpaceBioSpace · Thu, 06 Aug 2026 11:21:46 GMTBezos, Gates back LifeMine's transplant aspirations in $263M raise - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 10:31:57 GMT‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 10:30:00 GMTGreg Verdine’s LifeMine raises $263M for safer immunosuppressant - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 10:30:00 GMTLifeMine Therapeutics raises $263M; investors include Bezos, Gates funds - The Business JournalsThe Business Journals · Thu, 06 Aug 2026 10:30:00 GMT